News
LGT Capital Partners-advised entities support Nemera’s strategic ambitions with minority investment
Entities advised by LGT Capital Partners have acquired a minority stake in Nemera, a global manufacturer of drug delivery devices. LGT Capital Partners joins the existing owners, private equity firms Montagu and Astorg, to support Nemera’s future growth plans.
Nemera designs, develops and manufactures complex drug delivery devices from seven manufacturing sites in France, the US, Germany, Poland and Brazil. The company serves pharmaceutical, biotech and generics customers worldwide and offers end-to-end solutions from early design to large-scale production for both proprietary devices and contract manufacturing.
With the support of Montagu and Astorg, Nemera has grown in both scale and strategic value over the past six years. Now, with continued shareholder support and LGT Capital Partners joining as a minority investor, the company intends to accelerate its growth plans. Strategic priorities include enhancing its portfolio, expanding manufacturing capacity and investing in innovation and operational excellence to meet rising global demand.
Andreas Hellmann, Partner at LGT Capital Partners, said: “We are pleased to join Nemera as a minority investor at an important stage in its growth journey. Having followed the company over a number of years, we appreciate its commitment to innovation and focus on improving patients’ lives, as well as its effective leadership. We look forward to supporting the management team and existing shareholders, Montagu and Astorg, as the company continues to scale globally and provide advanced solutions to its partners and patients.”
Please see here for the media releases of Montagu and Astorg.
LGT Capital Partners has been active as a global direct minority investor since 2010. The investment in Nemera is closely aligned with the firm’s focus on being a leading global provider of capital solutions for private equity fund managers and their portfolio companies. LGT Capital Partners regularly partners with private equity sponsors by acquiring minority stakes in some of their best performing companies to support their capital needs and to facilitate longer-term value creation.
